Koji Ishida
Directeur/Bestuurslid bij Sumitomo Pharma America, Inc.
Oorsprong van het eerstegraads netwerk van Koji Ishida
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | General Government | 16 | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
Graduate School of Economics University of Tokyo
2
| College/University | Other Consumer Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Koji Ishida via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member General Counsel Corporate Officer/Principal | |
| University of Tokyo | College/University | Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member | |
| Keio University | College/University | Undergraduate Degree Undergraduate Degree | |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Doctorate Degree | |
| Boston College | College/University | Doctorate Degree | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | President | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KURITA WATER INDUSTRIES LTD. | Miscellaneous Manufacturing | Director/Board Member | |
| TOKYO ELECTRIC POWER COMPANY HOLDINGS, INC. | Electric Utilities | Director/Board Member | |
| DAH SING FINANCIAL HOLDINGS LIMITED | Regional Banks | Director/Board Member | |
| Beijing Pharmasciences Co. Ltd. | Chief Executive Officer | ||
MOL Ferry Co., Ltd.
 MOL Ferry Co., Ltd. Hotels/Resorts/Cruise linesConsumer Services Part of Mitsui O.S.K. Lines, Ltd., MOL Ferry Co., Ltd. operates a passenger shipping line business, freight forwarding, and cargo transport services. The company is based in Tokyo, Japan. | Hotels/Resorts/Cruise lines | President | |
| MITSUI O.S.K. LINES LTD | Marine Shipping | Corporate Officer/Principal | |
| Swiss Reinsurance Co. (Singapore Branch) | Director/Board Member | ||
| MITSUBISHI ESTATE CO., LTD. | Real Estate Development | Director/Board Member | |
The Bank for International Settlements
 The Bank for International Settlements General GovernmentGovernment Bank for International Settlements engages in the provision of financial banking services. It supports other central banks' pursuit of monetary and financial stability through international cooperation, and acts as a bank for the central banks. It offers a forum for dialogue and cooperation, a platform for responsible innovation and knowledge-sharing, and analysis and insights on core policies, and financial services. The company was founded in 1930 and is headquartered in Basel, Switzerland. | General Government | Chairman | |
| Kyoto University | College/University | Corporate Officer/Principal | |
| The University of Chicago | College/University | Graduate Degree | |
| University of Science & Technology of China | College/University | Undergraduate Degree | |
| Daiamed LLC | Chief Tech/Sci/R&D Officer | ||
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BLACKROCK, INC. | Investment Managers | Director/Board Member | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member | |
| Hiroshima University | College/University | Doctorate Degree | |
Meltin MMI KK
 Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Financial Services Agency | General Government | Corporate Officer/Principal | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member | |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Chemicals: Major Diversified | Director/Board Member | |
| TOBISHIMA CORPORATION | Engineering & Construction | Director/Board Member | |
| SBI SHINSEI BANK | Financial Conglomerates | Corporate Officer/Principal | |
Tolero Pharmaceuticals, Inc.
 Tolero Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Tolero Pharmaceuticals, Inc. manufactures and markets pharmaceutical products. It is a clinical-stage biopharmaceutical company with a single-minded purpose to alleviate human suffering through the development of medicines to treat cancer and other serious human diseases. The company is headquartered in Lehi, UT. | Pharmaceuticals: Other | Director/Board Member | |
| MITSUBOSHI BELTING LTD. | Auto Parts: OEM | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
| Kobe University | College/University | Corporate Officer/Principal | |
Primetals Technologies Ltd.
 Primetals Technologies Ltd. Information Technology ServicesTechnology Services Primetals Technologies Ltd. operates as a engineering and plant construction company. It manures of steel and iron products. The company was founded in January 2015 and is headquartered in London, the United Kingdom. | Information Technology Services | Director of Finance/CFO | |
Daiwa Institute of Research Ltd.
 Daiwa Institute of Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Daiwa Securities Group, Inc., Daiwa Institute of Research Ltd. conducts economic research and provides financial and investment advisory services. The company is based in Tokyo, Japan. The Japanese company was founded in 2008. Yoriyuki Kusaki has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Economist | |
UCB Research, Inc.
 UCB Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, UCB Research, Inc. is a company that provides commercial physical research laboratory services. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Banque du Japon Ltd.
 Banque du Japon Ltd. Financial ConglomeratesFinance Part of Bank of Japan, Banque du Japon Ltd. operates as a British dormant company. The company is based in London, UK. Founded in 2016. | Financial Conglomerates | Director/Board Member | |
| MEDEXUS PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| TOYOTA MOTOR CORPORATION | Motor Vehicles | Director/Board Member |
Statistieken
Internationaal
| Japan | 22 |
| Verenigde Staten | 18 |
| Verenigd Koninkrijk | 6 |
| China | 3 |
| Hongkong | 2 |
Sectoraal
| Health Technology | 17 |
| Consumer Services | 12 |
| Finance | 8 |
| Commercial Services | 4 |
| Producer Manufacturing | 3 |
Operationeel
| Director/Board Member | 69 |
| Corporate Officer/Principal | 41 |
| Undergraduate Degree | 13 |
| President | 12 |
| Independent Dir/Board Member | 11 |
Sterkste connecties
| Insiders | |
|---|---|
| Adele Gulfo | 16 |
| Yukitoshi Funo | 10 |
| Roger Xie | 10 |
| Shigeyuki Nishinaka | 9 |
| Masayo Tada | 8 |
| Hiroshi Nomura | 8 |
| Jack Britts | 7 |
| Haruhiko Kuroda | 7 |
| Masaaki Shirakawa | 7 |
| Seiji Nakamura | 6 |
| Ryuzo Miyao | 5 |
| Takako Masai | 5 |
| Takahide Kiuchi | 5 |
| Saburo Hamanaka | 4 |
| Sayuri Shirai | 3 |
- Beurs
- Insiders
- Koji Ishida
- Bedrijfsconnecties
